Adult-onset Still's disease: Clinical, serological and therapeutic considerations

Clinical and Experimental Rheumatology

Volumn 31, Issue 1, 2013, Pages 47-52

  Iliou, Chrisoula ^a   Papagoras, Charalampos ^a   Tsifetaki, Niki ^a   Voulgari, Paraskevi V ^a   Drosos, Alexandros A ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Adult onset Stills disease; Anakinra; C reactive protein; Corticosteroids; Methotrexate

Indexed keywords

ACETYLSALICYLIC ACID; C REACTIVE PROTEIN; CORTICOSTEROID; CYCLOSPORIN A; FERRITIN; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ABNORMAL LABORATORY RESULT; ADOLESCENT; ADULT; ADULT ONSET STILL DISEASE; AGED; ARTHRALGIA; ARTHRITIS; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE COURSE; DRUG RESPONSE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FERRITIN BLOOD LEVEL; FEVER; GREECE; HUMAN; HYPERFERRITINEMIA; HYPERTRANSAMINASEMIA; LEUKOCYTOSIS; MALE; NEUTROPHILIA; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RASH; RETROSPECTIVE STUDY; SORE THROAT; TREATMENT OUTCOME;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIRHEUMATIC AGENTS; ASPIRIN; BIOLOGICAL MARKERS; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; FEMALE; FERRITINS; GREECE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; MALE; METHOTREXATE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STILL'S DISEASE, ADULT-ONSET; TIME FACTORS; TREATMENT OUTCOME; UP-REGULATION; YOUNG ADULT;

EID: 84874909878     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. BAGNARI V, COLINA M, CIANCIO G, GOVONI M, TROTTA F. Adult-onset Still's disease. Rheumatol Int 2010; 30. 855-62.
2. OWLIA MB, MEHRPOOR G. Adult-onset Still's disease. a review. Indian J Med Sci 2009; 63. 207-21.
3. FAUTREL B. Adult-onset Still disease. Best Pract Res Clin Rheumatol 2008; 22. 773-92.
4. MAGADUR-JOLY G, BILLAUD E, BARRIER JH. Epidemiology of adult Still's disease. Estimate of the incidence by a retrospective study in west France. Ann Rheum Dis 1995; 54. 587-90.
5. LAHIRI M, TENG GG. A case of refractory adult-onset Still's disease treated with anakinra. Int J Rheum Dis 2010; 13. e36-41.
6. NAUMANN L, FEIST E, NATUSCH A. IL1-receptor antagonist anakinra provides longlasting efficacy in the treatment of refractory adult-onset Still's disease. Ann Rheum Dis 2010; 69. 466-7.
7. MOULIS G, SAILLER L, ASTUDILLO L, PUGNET G, ARLET P. May anakinra be used earlier in adult onset Still disease Clin Rheumatol 2010; 29. 1199-200.
8. LEQUERRE T, QUARTIER P, ROSELLINI D et al. Societe Francophone pour la Rhumatologie et les Maladies Inflammatoires en Pediatrie (SOFREMIP); Club Rhumatismes et Inflammation (CRI) Interleukin - 1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease. preliminary experience in France. Ann Rheum Dis 2008; 67. 302-8.
9. THONHOFER R, HILLER M, JUST H. Treatment of refractory adult-onset still's disease with tocilizumab. report of two cases and review of the literature. Rheumatol Int 2011; 31. 1653-8.
10. NANIWA T, ITO R, WATANABE M et al. Case report. successful use of short-term add-on tocilizumab for multirefractory systemic flare of adult-onset Still's disease. Clin Rheumatol 2010 Sep 15.
11. PUÉCHAL X, DEBANDT M, BERTHELOT JM et al. Club Rhumatismes et Inflammation. Tocilizumab in refractory adult Still's disease. Arthritis Care Res (Hoboken) 2011; 63. 155-9.
12. PERDAN-PIRKMAJER K, PRAPROTNIK S, TOMŠIČ M. A case of refractory adult-onset Still's disease successfully controlled with tocilizumab and a review of the literature. Clin Rheumatol 2010; 29. 1465-7.
13. RECH J, RONNEBERGER M, ENGLBRECHT M et al. Successful treatment of adult-onset Still's disease refractory to TNF and IL-1 blockade by IL-6 receptor blockade. Ann Rheum Dis 2011; 70. 390-2.
14. KRAETSCH HG, ANTONI C, KALDEN JR, MANGER B. Successful treatment of a small cohort of patients with adult onset of Still's disease with infliximab. first experiences. Ann Rheum Dis 2001; 60 (Suppl. 3). iii55-7.
15. DECHANT C, SCHAUENBERG P, ANTONI CE, KRAETSCH HG, KALDEN JR, MANGER B. Longterm outcome of TNF blockade in adult-onset Still's disease. Dtsch Med Wochenschr 2004; 129. 1308-12.
16. FAUTREL B, SIBILIA J, MARIETTE X, COMBE B; CLUB RHUMATISMES et al. Inflammation Tumour necrosis factor alpha blocking agents in refractory adult Still's disease. an observational study of 20 cases. Ann Rheum Dis 2005; 64. 262-6.
17. BARTOLONI E, ALUNNO A, LUCCIOLI F, SANTOBONI G, GERLI R. Successful treatment of refractory adult-onset Still's disease with anti-CD20 monoclonal antibody. Clin Exp Rheumatol 2009; 27. 888-9.
18. JIANG L, WANG Z, DAI X, JIN X. Evaluation of clinical measures and different criteria for diagnosis of adult-onset Still's disease in a Chinese population. J Rheumatol 2011; 38. 741-6.
19. RIERA E, OLIVÉ A, NARVÁEZ J et al. Adult onset Still's disease. review of 41 cases. Clin Exp Rheumatol 2011; 29. 331-6.
20. COLINA M, ZUCCHINI W, CIANCIO G, ORZINCOLO C, TROTTA F, GOVONI M. The Evolution of Adult-Onset Still Disease. An Observational and Comparative Study in a Cohort of 76 Italian Patients. Semin Arthritis Rheum 2011; 41. 279-85.
21. KONG XD, XU D, ZHANG W, ZHAO Y, ZENG X, ZHANG F. Clinical features and prognosis in adult-onset Still's disease. a study of 104 cases. Clin Rheumatol 2010; 29. 1015-9.
22. CAGATAY Y, GUL A, CAGATAY A et al. Adultonset Still's disease. Int J Clin Pract 2009; 63. 1050-5.
23. MEHRPOOR G, OWLIA MB, SOLEIMANI H, AYATOLLAHI J. Adult-onset Still's disease. a report of 28 cases and review of the literature. Mod Rheumatol 2008; 18. 480-5.
24. APPENZELLER S, CASTRO GR, COSTALLAT LT, SAMARA AM, BÉRTOLO MB. Adult-onset Still disease in southeast Brazil. J Clin Rheumatol 2005; 11. 76-80.
25. YAMAGUSHI M, OHTA A, TSUNEMATSU T et al. Preliminary criteria for classification of adult Still's disease. J Rheumatol 1992; 19. 424-30.
26. FAUTREL B, ZING E, GOLMARD JL et al. Proposal for a new set of classification criteria for adult-onset still disease. Medicine (Baltimore) 2002; 81. 194-200.
27. CUSH JJ, MEDSGER TA JR, CHRISTY WC, HERBERT DC, COOPERSTEIN LA. Adult-onset Still's disease. Clinical course and outcome. Arthritis Rheum 1987; 30. 186-94.
28. RAU M, SCHILLER M, KRIENKE S, HEYDER P, LORENZ H, BLANK N. Clinical manifestations but not cytokine profiles differentiate adult-onset Still's disease and sepsis. J Rheumatol 2010; 37. 2369-76.
29. LIAN F, WANG Y, YANG X, XU H, LIANG L. Clinical features and hyperferritinemia diagnostic cutoff points for AOSD based on ROC curve. a Chinese experience. Rheumatol Int 2012; 32. 189-92.
30. NOVAK S, ANIC F, LUKE-VRBANIĆ TS. Extremely high serum ferritin levels as a main diagnostic tool of adult-onset Still's disease. Rheumatol Int 2012; 32. 1091-4.
31. FAUTREL B, LE MOEL G, SAINT-MARCOUX B et al. Diagnostic value of ferritin and glycosylated ferritin in adult onset Still's disease. J Rheumatol 2001; 28. 322-9.
32. MANGER B, RECH J, SCHETT G. Use of MTX in adult-onset Still's disease. Clin Exp Rheumatol 2010; 28 (Suppl. 61). S168-71.
33. MITAMURA M, TADA Y, KOARADA S et al. Cyclosporin A treatment for Japanese patients with severe adult-onset Still's disease. Mod Rheumatol 2009; 19. 57-63.
34. FRANCHINI S, DAGNA L, SALVO F, AIELLO P, BALDISSERA E, SABBADINI MG. Efficacy of traditional and biologic agents in different clinical phenotypes of adult-onset Still's disease. Arthritis Rheum 2010; 62. 2530-5.